Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
9.83
-0.48 (-4.66%)
Jul 1, 2026, 4:00 PM EDT - Market closed
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $699.8 million as of July 1, 2026. Its market cap has increased by 946.89% in one year.
Market Cap
699.80M
Enterprise Value
610.26M
1-Year Change
946.89%
Ranking
Category
Stock Price
$9.83
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $699.80M, an increase of 964.43%. That is a compound annual growth rate of 68.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 699.80M | 153.92% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 790.48M |
| Allogene Therapeutics | 766.24M |
| Climb Bio | 765.00M |
| Inventiva | 761.81M |
| Candel Therapeutics | 759.08M |
| Aura Biosciences | 758.86M |
| Nuvectis Pharma | 756.77M |
| Relmada Therapeutics | 732.13M |